Showing results (801-810 of 988) with videos related to
Sort By:
Pageof 99
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|November 3, 2020
Targeted Molecular Therapies in Allergy and RhinologyCecelia C Damask, Matthew W Ryan, Thomas B Casale, et al.Clinical Chemistry|February 1, 1982
A candidate reference method for uric acid in serum. II. Interlaboratory testingP Duncan, N Gochman, D Bayse, et al.Emerging Infectious Diseases|April 23, 2010
Historical distribution and molecular diversity of Bacillus anthracis, KazakhstanAlim M Aikembayev, Larissa Lukhnova, Gulnara Temiraliyeva, et al.Investigational New Drugs|November 29, 2014
A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancerJoshi J Alumkal, Rachel Slottke, Jacob Schwartzman, et al.Annals of the Rheumatic Diseases|July 21, 2010
Variants in linkage disequilibrium with the late cornified envelope gene cluster deletion are associated with susceptibility to psoriatic arthritisJohn Bowes, Edward Flynn, Pauline Ho, et al.BMC Medical Genetics|May 19, 2010
Evaluation of 6 candidate genes on chromosome 11q23 for coeliac disease susceptibility: a case control studyKaren Brophy, Anthony W Ryan, Graham Turner, et al.Cancer|April 21, 2021
A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: High-grade neuroendocrine neoplasm cohortSandip Pravin Patel, Edward Mayerson, Young Kwang Chae, et al.Circulation|November 9, 2005
Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) RegistryJason W Ryan, Eric D Peterson, Anita Y Chen, et al.Environmental Science & Technology|July 24, 2025
The Associations of Air Pollution Mixture Exposure with Plasma Proteins in an Elderly U.S. PanelZiyin Tang, Ying Wang, Jeremy A Sarnat, et al.JAMA Network Open|August 6, 2024
Adjuvant Everolimus in Non-Clear Cell Renal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical TrialShuchi Gulati, Catherine Tangen, Christopher W Ryan, et al.Pageof 99